Company Info
Phone(508) 832-5400
Year Established
1981
Ticker
RGEN
Exchange
NASDAQ
Contacts
Tony J. HuntExecutive Chair
Jason K. Garland
CFO
James R. Bylund
COO
Olivier Loeillot
President & CEO
Ralf Kuriyel
Senior VP, R&D
Kola Otitoju
Senior VP, Business Development
Company Description
Repligen develops and manufactures products for the biopharmaceutical industry under an ISO 9001 quality management system.